cordycepin has been researched along with Demyelinating Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, H; Chen, X; Du, J; Feng, L; Hou, Y; Jia, Y; Li, H; Luo, S; Wang, C; Wang, G; Xiao, C; Xiao, L; Xiao, Y; Yu, H; Zhang, D; Zhang, Y; Zhou, J; Zhu, K | 1 |
1 other study(ies) available for cordycepin and Demyelinating Diseases
| Article | Year |
|---|---|
Cordycepin (3'-deoxyadenosine) promotes remyelination via suppression of neuroinflammation in a cuprizone-induced mouse model of demyelination.
Topics: Animals; Anti-Inflammatory Agents; Astrocytes; Corpus Callosum; Cuprizone; Cytokines; Demyelinating Diseases; Deoxyadenosines; Disease Models, Animal; Hippocampus; Male; Mice; Mice, Inbred C57BL; Neuroglia; Neuroprotective Agents; Remyelination | 2019 |